Hematology

The Department of Hematology diagnoses and treats anemia, leukemia, leukocytopenia, thrombocytopenia, coagulation disorders, leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. Diagnosis relies on comprehensive typing using complete blood counts, bone marrow morphology, flow cytometry, cytogenetics, and molecular testing. Treatment includes chemotherapy, targeted therapy, immunotherapy, hematopoietic stem cell transplantation, and supportive care. For high-risk diseases such as acute leukemia, early standardized stratification and intensive treatment are closely related to prognosis; for chronic hematological diseases, long-term management and complication prevention are emphasized. During treatment, attention must be paid to infection, bleeding, tumor lysis, thrombosis, and organ toxicity. Emergency treatment should be prioritized if high fever, neutropenia, disseminated intravascular coagulation, high leukocytosis, or spinal cord compression occur. Long-term follow-up requires attention to relapse monitoring, vaccination, fertility protection, and psychological support.